When will Compass Pathways submit a NDA for COMP360 psilocybin?
14.0 pts (24h)Health & MedicineOne-OffCiênciaBusiness & Corporate21d
KalshiVerificar disponibilidadeKYC obrigatório2% de taxaDados de resolução verificadosRazoavelmente calibradoProbabilidade implícita atual
before April 2027 83%Líder entre 6 opções
Qualidade do mercado
42 / 100
Baixa qualidadeVolume 24h
997,3 €
Liquidez
8,7 mil €
Liquidez médiaSpread
20.0 pt
Spread amploDados do mercado
Atualizado há 7 minutos
24/03/26, 14:00 UTC1/10/26, 14:00 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill psilocybin remain Schedule I through the end of 2027?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRegras
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Mercados abertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 30,4 mil
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- € 652,8 mil
- Volume 24h
- € 3,5 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Volume total
- € 1,6 mi
- Volume 24h
- € 2,9 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 mais resultados
- Volume total
- € 865,3 mil
- Volume 24h
- € 2,7 mil
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volume total
- € 915,3 mil
- Volume 24h
- € 1,4 mil
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Volume total
- € 84 mil
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
- Heidi Overton confirmed as FDA Commissioner by which date?
Perguntas frequentes
- Quais são as probabilidades atuais de When will Compass Pathways submit a NDA for COMP360 psilocybin??
- A Kalshi cota before April 2027 em 83% em 9 de setembro de 2026.
- Quando When will Compass Pathways submit a NDA for COMP360 psilocybin? é resolvido?
- When will Compass Pathways submit a NDA for COMP360 psilocybin? deverá ser resolvido em 1 de outubro de 2026.
- Como When will Compass Pathways submit a NDA for COMP360 psilocybin? é liquidado?
- A Kalshi liquida este mercado da seguinte forma: If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.